Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Can Garmin Ltd. (GRMN) Get Over Its Shortcomings?

Page 1 of 2

On Aug. 15, satellite navigation company Garmin Ltd. (NASDAQ:GRMN) moved from No. 10 to No. 4 on DividendChannel’s list of the Nasdaq 100’s most shorted companies, beating out previous fourth-placer, generic-drug company Mylan Inc. (NASDAQ:MYL), along the way.

It may not be the top spot, and it’s slightly lower than Garmin Ltd. (NASDAQ:GRMN) has been in the past, but it still shows the GPS company is one of the most heavily bet-against stocks on the market. Let’s dig a little deeper to see what could be at the root of this new statistic, and whether it means investors should change direction.

Explaining the short
The DividendChannel compiles its most-shorted list by looking at a company’s days to cover, or the number of days it would take for investors to buy the same amount of shares as are being shorted. To find this, take the current amount of shorted shares (or short interest) and divide that by a company’s average daily share volume. Garmin Ltd. (NASDAQ:GRMN) clocked in at 14.10 days, while the Nasdaq’s average is around 4.27.

Garmin Ltd. (NASDAQ:GRMN)As of Aug. 15, the amount of shorted Garmin Ltd. (NASDAQ:GRMN) shares actually went down from 13.08 million on July 31, to 11.63 million. Unfortunately, so did its average daily share volume — that metric came out to 824,265 shares, which is quite the drop from the 1.3 million shares being traded at the end of July.

Weakening hold on the market
So what is causing the drop in shares, and thus the rising days to cover? One possible reason might be Garmin Ltd. (NASDAQ:GRMN)’s shaky hold on its market share.

Over the past few years, Garmin Ltd. (NASDAQ:GRMN)’s revenue has shrunk while its industry’s has expanded, reducing the company’s market share as a result. According to the Satellite Industry Association, in both 2011 and 2012 the satellite navigation industry brought in $32.2 billion in revenue. Garmin brought in $2.71 billion of that, making up 8.4% of market share. This is a 44% drop from Garmin’s 15% market share in 2007, when the industry was worth approximately $20.8 billion and the company was raking in $3.1 billion.

Adding to Garmin Ltd. (NASDAQ:GRMN)’s troubles is of course the fact that more and more people are opting to use smartphones and tablets for their GPS/mapping needs. When Google Inc (NASDAQ:GOOGreleased a new (free) Maps app for iOS users in December 2012, it racked up a stunning 10 million downloads in less than 48 hours, while Garmin only sold 15.4 million units in the whole of 2012. When a company starts to lose its footing in revenue like this, short-sellers and investors alike start to take notice.

Deceptive dividend
Despite its declining revenue, Garmin Ltd. (NASDAQ:GRMN) continues to pay a quarterly dividend that currently yields 4.3%. In June 2012, the company announced it was raising its quarterly amount 12.5% to $0.45 per share.

While that sounds promising, it’s worth noting that Garmin Ltd. (NASDAQ:GRMN) has not exactly been consistent in how much it pays shareholders as of late. Instead of steadily upping its quarterly payout over time (a trait dividend investors love), the company has given special dividends when it can (most recently in June 2011), before cutting its regular payout from $0.75 per share to $0.40. At its current rate of $0.45 per share, Garmin’s payout is still lower than it was when the company first started doling out dividends of $0.50 per share in 2003. For the dividend investor who has been on board with Garmin since its beginning, this stat is hard to ignore, and could serve as a reason to start second-guessing.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!